483 Lawrence Levinson, M.D. Sep 2018

483 Lawrence Levinson, M.D. Sep 2018

Kelly Kerr FDA$119.00 - Available Now

FDA investigators audited the Lawrence Levinson, M.D. - Altoona, PA, United States facility and issued inspectional observations (via FDA 483) on 06 Sep 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Sep 2018
  • Location: Altoona, United States
  • FEI: 3010794556
Add To Cart